Skip Page Header

Home > National hepatitis C database: for infection acquired through blood and blood products. 2012 report.

Health Protection Surveillance Centre. (2012) National hepatitis C database: for infection acquired through blood and blood products. 2012 report. Dublin: Health Service Executive.

[img]
Preview
PDF (National hepatitis C database 2012) - Published Version
2MB

Hepatitis C virus (HCV) infection is a major cause of liver disease and death throughout the world. Between 55% and 85% of those infected develop chronic infection. It is estimated that up to 20% of those with chronic infection will develop cirrhosis of the liver over 20-25 years, with 3-4% of these developing hepatocellular carcinoma per year. Very effective treatments for HCV are now available which eradicate the virus in over 50% of cases depending on the genotype. The virus is transmitted by blood and now occurs primarily through injecting drug use. Transfusion-related HCV infection is rare now since the introduction of routine screening of blood in the early 1990s.

The National Hepatitis C Database was set up in 2004 to collect data on people infected with HCV through the receipt of contaminated blood and blood products in Ireland. Approximately 1,700 people were infected through anti-D immunoglobulin, blood transfusion, blood clotting factors or treatment for renal disease. The purpose of the database project is to follow the natural history of infection, evaluate the outcomes of treatment, provide information for planning of services, and serve as a resource for research. This report is based on the fourth round of data collection and includes data on database participants up to the end of 2009.


Item Type
Report
Date
2012
Pages
70 p.
Publisher
Health Service Executive
Corporate Creators
Health Protection Surveillance Centre
Place of Publication
Dublin
ISBN
978-0-9551236-2-7
EndNote
Accession Number
HRB (Electronic Only)

Repository Staff Only: item control page